Literature DB >> 6989034

A gerbil model of cerebral ischemia suitable for drug evaluation.

D M Jarrott, F R Domer.   

Abstract

Cerebral ischemia was produced in the Mongolian gerbil by bilateral occlusion of the carotid arteries. Although the cerebral ischemia so produced was not total, a mortality rate of 100% was obtained if the occlusion was maintained for 60 min in gerbils weighing 45--55 gm. Few deaths were observed after 50 min of bilateral carotid arterial occlusion. Test drugs were administered, after the removal of the arterial clips, to groups of gerbils to determine the mortality rate associated with each drug. Isoproterenol 50 mg/kg, amphetamine 5.0 mg/kg, and methylprednisolone 35 mg/kg improved survival after cerebral ischemia. Atropine 1 mg/kg, thiosemicarbazide 4 mg/kg, aminooxyacetic acid 100 mg/kg, theophylline 100 mg/kg, and phenytoin 50 mg/kg were associated with a reduced survival after cerebral ischemia. The known tendency of the gerbil to exhibit spontaneous seizures and the frequency and severity of the observed post-ischemic seizures suggest that the lethality of prolonged cerebral ischemia may be, in part, related to seizures triggered by the cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989034     DOI: 10.1161/01.str.11.2.203

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Regional profiles of steady-state levels of cyclic nucleotides, cyclic AMP phosphodiesterase, and guanylate cyclase activities during late stages of unilateral ischemia in gerbil forebrain.

Authors:  G C Palmer; B C Christie-Pope; M A Medina; P M Colombo; S J Palmer
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

2.  The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.

Authors:  C D Nicholson; S A Jackman; R Wilke
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  Effect of ischemia on noradrenergic and energy-related metabolites in the cerebral cortex of young and adult gerbils.

Authors:  K Kumami; B B Mrsulja; Y Ueki; B D Djuricić; M Spatz
Journal:  Metab Brain Dis       Date:  1988-12       Impact factor: 3.584

4.  Evolution and resolution of oedema following severe temporary cerebral ischaemia in the gerbil.

Authors:  S Avery; H A Crockard; R R Russell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-06       Impact factor: 10.154

5.  Modulation of ischemic-induced damage to cerebral adenylate cyclase in gerbils by calcium channel blockers.

Authors:  B C Christie-Pope; G C Palmer
Journal:  Metab Brain Dis       Date:  1986-12       Impact factor: 3.584

6.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

7.  YES-10, A Combination of Extracts from Clematis mandshurica RUPR. and Erigeron annuus (L.) PERS., Prevents Ischemic Brain Injury in A Gerbil Model of Transient Forebrain Ischemia.

Authors:  Tae-Kyeong Lee; Joon Ha Park; Bora Kim; Young Eun Park; Jae-Chul Lee; Ji Hyeon Ahn; Cheol Woo Park; Yoohun Noh; Ji-Won Lee; Sung-Su Kim; Jong Dai Kim; Moo-Ho Won
Journal:  Plants (Basel)       Date:  2020-01-26

8.  Therapeutic effects of stiripentol against ischemia-reperfusion injury in gerbils focusing on cognitive deficit, neuronal death, astrocyte damage and blood brain barrier leakage in the hippocampus.

Authors:  Myoung Cheol Shin; Tae-Kyeong Lee; Jae-Chul Lee; Hyung Il Kim; Chan Woo Park; Jun Hwi Cho; Dae Won Kim; Ji Hyeon Ahn; Moo-Ho Won; Choong-Hyun Lee
Journal:  Korean J Physiol Pharmacol       Date:  2022-01-01       Impact factor: 2.016

9.  Astaxanthin Confers a Significant Attenuation of Hippocampal Neuronal Loss Induced by Severe Ischemia-Reperfusion Injury in Gerbils by Reducing Oxidative Stress.

Authors:  Joon Ha Park; Tae-Kyeong Lee; Dae Won Kim; Ji Hyeon Ahn; Choong-Hyun Lee; Jong-Dai Kim; Myoung Cheol Shin; Jun Hwi Cho; Jae-Chul Lee; Moo-Ho Won; Soo Young Choi
Journal:  Mar Drugs       Date:  2022-04-14       Impact factor: 6.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.